Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT

Clinical Nuclear Medicine

Volumn 24, Issue 9, 1999, Pages 660-665

  Varrone, Andrea ^a   Soricelli, Andrea ^a   Postiglione, Alfredo ^a   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Brain Perfusion; Gamma Aminobutyric Acid A Receptors; Synaptic Density; Tomography

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; IOMAZENIL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN PERFUSION; CLINICAL ARTICLE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FRONTAL LOBE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARIETAL LOBE; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

ALZHEIMER DISEASE; BRAIN; FEMALE; FLUMAZENIL; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032817447     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199909000-00004     Document Type: Article

References (31)

1. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL: Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine 1-123. Arch Neurol 44:165, 1987.
2. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A: The scintigraphic appearance of Alzheimer's disease: A prospective study using Technetium-99m-HMPAO-SPECT. J Nucl Med 33:181, 1992.
3. Johnson KA, Kijewski MF, Becker A, et al: Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 34:2044, 1993.
4. Messa C, Perani D, Lucignani G, et al: High-resolution Technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG PET. J Nucl Med 35:210, 1994.
5. Rapoport SI: Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovascular and Brain Metabolism Reviews 3:297, 1991.
6. De Kosky ST, Bass NH: Biochemistry of senile dementia. In: Laitha A, ed. Handbook of Neurochemistry. New York: Plenum Press, 1985, pp 617-49.
7. Selkoe DJ: Aging, amyloid, and Alzheimer's disease. N Engl J Med 320:1484, 1989.
8. Terry RD, Peck A, De Teresa R, Schlechter R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184, 1981.
9. Yamaguchi F, Hirai S, Morimatso M, et al: A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β-protein immunostaining. Acta Neuropathol 76:541, 1988.
10. Tc-99m-HMPAO SPECT. Neuroradiology 36:1, 1994.
11. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R: A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 55:1182, 1992.
12. Cohen D, Krausz Y, Lossos A, Ben-David E, Atlan H: Brain SPECT imaging with Tc-99m HM-PAO in Creutzfeld-Jakob disease. Clin Nucl Med 14:808, 1989.
13. Grunwald F, Zierz S, Broich K, et al: HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med 31:1740, 1990.
14. Kuwabara Y, Ichiya Y, Otsuka M, et al: Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 15:893, 1990.
15. Innis R, Zoghbi S, Johnson E, et al: SPECT imaging of the benzodiazepine receptor in non-human primate brain with [I-123]Ro 16-0154. Eur J Pharmacol 193:249, 1991.
16. Woods SW, Seibyl JP, Goddard AW, et al: Dynamic SPECT imaging after the injection of the benzodiazepine receptor ligand [I-123]iomazenil in healthy human subjects. Psychiatry Res Neuroimaging 45:67, 1992.
17. Abi-Dargham A, Laurelle M, Seibyl J, et al: SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35:228, 1994.
18. Abi-Dargham A, Gandelman M, Zoghbi SS, et al: Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodinc-123-iomazcnil. J Nucl Med 36:167, 1995.
19. Soricelli A, Postiglione A, Grivet-Fojaia MR, et al: Preliminary evaluation of distribution volume for 123-I-iomazenil in Alzheimer's disease as a measure of loss of synapses. Eur J Nucl Med 23:1323, 1996.
20. Fukuchi K, Hashikawa K, Seike Y, et al: Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease. J Nucl Med 38:467, 1997.
21. Onishi Y, Yonekura Y, Takao M, et al: Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans. J Nucl Med 36: 1201, 1995.
22. Onishi Y, Yonekura Y, Nishizawa S, et al: Noninvasive quantification of iodine-123-iomazenil SPECT. J Nucl Med 37:374, 1996.
23. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939, 1984.
24. Hachinski VC, Iliff LD, Zilhka E, et al: Cerebral blood flow in dementia. Arch Neurol 32:632, 1975.
25. Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136, 1982.
26. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: A pratical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189, 1975.
27. Genna S, Smith AP: The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci 35:654, 1988.
28. Chang L-T: A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 25:638, 1978.
29. Lassen NA, Andersen AR, Friberg L, Paulson OB: The retention of [Tc-99m]-d,l,-HMPAO in the human brain after intracarotid bolus injection: A kinetic analysis. J Cereb Blood Flow Metab 8:S13, 1988.
30. Neirinckx RD, Burke JF, Harrison RC, et al: The retention mechanism of technetium-99m-HMPAO: Intracellular reaction with glutathione. J Cereb Blood Flow Metab 8:S4 1988.
31. Payne JK, Trivedi MH, Devous MD: Comparison of technetium-99m-HMPAO and Xenon-133 measurements of regional cerebral blood flow by SPECT. J Nucl Med 37:1735, 1996.